Swedbank Ab Optimize Rx Corp Transaction History

Swedbank Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 09, 2024	SELL	$13.74 - $30.13 $1.1 Million - $2.41 Million	-79,960 Closed	0 $0
Q2 2022 Dec 09, 2024	BUY	$21.94 - $40.49 $438,800 - $809,800	20,000 Added 33.36%	79,960 $2.19 Million
Q4 2021 Dec 09, 2024	SELL	$53.57 - $98.0 $267,850 - $490,000	-5,000 Reduced 7.7%	59,960 $3.72 Million
Q3 2021 Dec 09, 2024	SELL	$50.93 - $85.55 $763,950 - $1.28 Million	-15,000 Reduced 18.76%	64,960 $5.56 Million
Q2 2021 Dec 09, 2024	SELL	$42.76 - $63.33 $213,800 - $316,650	-5,000 Reduced 5.89%	79,960 $4.95 Million
Q1 2021 Dec 09, 2024	BUY	$33.36 - $62.2 $2.83 Million - $5.28 Million	84,960 New	84,960 $4.14 Million

12.2M

800

18.1K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $99.1M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.